Qiagen Pharmacogenomic Insights

Qiagen's Digital Insights business has launched Pharmacogenomic Insights (PGXI), a knowledgebase designed to help scientific and translational researchers better understand how an individual's genetic make-up influences their response to medications. The knowledgebase contains data from all established pharmacogenomic information sources, including the US Food and Drug Administration, the Clinical Pharmacogenetics Implementation Consortium, the Dutch Pharmacogenetics Working Group, the Pharmacogene Variation Consortium, and curated articles from the biomedical literature database PubMed, to provide accurate, up-to-date evidence in one centralized location. Users can submit pharmacogenomic test results to PGXI and rapidly query and identify relevant gene-drug associations and conditions linked to specific genotypes.